The use of second-generation PHGDH inhibitors (PH-719 and PH-755) inhibits the growth of breast cancer and colon cancer cells in serine-limited environments and attenuates breast cancer brain metastasis [11,31]. Here, PHGDH is linked to malignant colon neoplasm.